OVARIAN CANCER PRIMARY PERITONEAL Clinical Trials
7 clinical trials for OVARIAN CANCER PRIMARY PERITONEAL across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.
- A PHASE 2/3, MULTICENTER, RANDOMIZED STUDY OF RALUDOTATUG DERUXTECAN (RDXD), A CDH6-DIRECTED ANTIBODY-DRUG CONJUGATE, IN SUBJECTS WITH PLATINUMRESISTANT, HIGH-GRADE OVARIAN, PRIMARY PERITONEAL, OR FALLOPIAN TUBE CANCER — RECRUITING · PHASE2
- MULTICENTER, OPEN-LABEL, PHASE 2 STUDY OF CARBOPLATIN PLUS MIRVETUXIMAB SORAVTANSINE FOLLOWED BY MIRVETUXIMAB SORAVTANSINE CONTINUATION IN FOLATE RECEPTOR-ALPHA POSITIVE, RECURRENT PLATINUM-SENSITIVE, HIGH-GRADE EPITHELIAL OVARIAN, PRIMARY PERITONEAL OR FALLOPIAN TUBE CANCERS FOLLOWING 1 PRIOR LINE OF PLATINUM-BASED CHEMOTHERAPY — RECRUITING · PHASE2
- A PHASE 2, OPEN-LABEL, SINGLE-ARM STUDY TO EVALUATE THE SAFETY AND EFFICACY OF NIRAPARIB IN PATIENTS WITH ADVANCED, RELAPSED, HIGH-GRADE SEROUS EPITHELIAL OVARIAN, FALLOPIAN TUBE, OR PRIMARY PERITONEAL CANCER WHO HAVE RECEIVED THREE OR FOUR PREVIOUS CHEMOTHERAPY REGIMENS — RECRUITING · PHASE2
- "A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL OF PEGYLATE LIPOSOMAL DOXORUBIN (PLD) PLUS AMG 386 OR PLACEBO IN WOMEN IN RECURRENT PARTIALLY PLATINUM SENSITIVE OR RESISTANT EPITHELIAL OVARIAN, PRIMARY PERITONEAL, OR FALLOPIAN TUBE CANCER," — RECRUITING · PHASE3
- A MULTICENTRE RANDOMISED PHASE II STUDY OF AZD1775 PLUS CHEMOTHERAPY VERSUS CHEMOTHERAPY ALONE IN PATIENTS WITH PLATINUM-RESISTANT TP53-MUTATED EPITHELIAL OVARIAN, FALLOPIAN TUBE, OR PRIMARY PERITONEAL CANCER — COMPLETED · PHASE2
- A PHASE I/II, OPEN-LABEL, SAFETY, PHARMACOKINETIC, AND PRELIMINARY EFFICACY STUDY OF ORAL RUCAPARIB IN PATIENTS WITH GBRCA OVARIAN CANCER OR OTHER SOLID TUMOR — COMPLETED · PHASE1
- A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY OF RUCAPARIB AS SWITCH MAINTENANCE FOLLOWING PLATINUM-BASED CHEMOTHERAPY IN PATIENTS WITH PLATINUM-SENSITIVE, HIGH-GRADE SEROUS OR ENDOMETRIOID EPITHELIAL OVARIAN, PRIMARY PERITONEAL OR FALLOPIAN TUBE CANCER — COMPLETED · PHASE3
Refine this search